D. Osborne

Director of Finance/CFO at Melt Pharmaceuticals, Inc.

45 year

Health Technology

Active connections

Name	Gender	Age	Linked companies	Collaboration
Helen Sabzevari	M	62	PRECIGEN, INC.	5 years
Larry Dillaha	M	60	Melt Pharmaceuticals, Inc. Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.	3 years
Jeffrey Perez	M	52	PRECIGEN, INC.	10 years
Fred Hassan	M	78	PRECIGEN, INC.	8 years
Jeffrey Kindler	M	68	PRECIGEN, INC.	13 years
James Turley	M	68	PRECIGEN, INC.	10 years
Vinita Deshbandhu Gupta	F	56	PRECIGEN, INC.	7 years
Arthur Laffer	M	83	Melt Pharmaceuticals, Inc. Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.	2 years
Mark Baum	M	51	Melt Pharmaceuticals, Inc. Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.	-
J. Corley	M	68	Melt Pharmaceuticals, Inc. Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.	5 years
Steven M. Harasym	M	-	PRECIGEN, INC.	6 years
John Berdahl	M	-	Melt Pharmaceuticals, Inc. Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.	-
Giovanni de Castro	M	-	Melt Pharmaceuticals, Inc. Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.	3 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Samuel Broder	M	79	PRECIGEN, INC.	2 years
Thomas David Reed	M	58	PRECIGEN, INC.	22 years
Robert Beech	M	71	PRECIGEN, INC.	8 years
Robert Shapiro	M	85	PRECIGEN, INC.	12 years
Larry D. Horner	M	90	PRECIGEN, INC.	7 years
Marie L. Rossi	M	-	PRECIGEN, INC.	9 years
Thomas Shrader	M	-	PRECIGEN, INC.	-
Olivier R. Jarry	M	63	PRECIGEN, INC.	-
James Vincent Lambert	M	60	PRECIGEN, INC.	1 years
Rick Sterling	M	60	PRECIGEN, INC.	14 years
Jack Anthony Bobo	M	58	PRECIGEN, INC.	-
Dana di Ferdinando	F	-	PRECIGEN, INC.	-
Christopher Basta	M	-	PRECIGEN, INC.	-
Kelly Huang	M	55	PRECIGEN, INC.	-
Grace Colón	M	57	PRECIGEN, INC.	2 years
Andy Bass	M	-	PRECIGEN, INC.	-
Fayaz Khazi	M	51	PRECIGEN, INC.	2 years
Thomas Bostick	M	67	PRECIGEN, INC.	3 years
Timothy D. Kasbe	M	58	PRECIGEN, INC.	-
Ena Chan Cratsenburg	F	-	PRECIGEN, INC.	-
Jayson M. Rieger	M	48	PRECIGEN, INC.	1 years
Nir Nimrodi	M	55	PRECIGEN, INC.	5 years
Robert F. Walsh	M	65	PRECIGEN, INC.	6 years
Geno Germano	M	63	PRECIGEN, INC.	1 years
Matthew Crisp	M	41	PRECIGEN, INC.	1 years
Peter Emtage	M	-	PRECIGEN, INC.	-
Hadyn Parry	M	-	PRECIGEN, INC.	-
Peter Seufer-Wasserthal	M	-	PRECIGEN, INC.	5 years
Joel A. Liffmann	M	63	PRECIGEN, INC.	4 years
Krish S. Krishnan	M	59	PRECIGEN, INC.	5 years
Saiid Zarrabian	M	71	PRECIGEN, INC.	1 years
Andrew Last	M	64	PRECIGEN, INC.	1 years
Suma M. Krishnan	F	59	PRECIGEN, INC.	4 years
Gregory Ian Frost	M	52	PRECIGEN, INC.	1 years
Chris Savile	M	-	PRECIGEN, INC.	4 years

Statistics

Country	Connections	% of total
United States	48	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections